Evaluation of PD-1/PD-L1 and CTLA-4 immune checkpoints and angiogenic activity in ovarian cancer after oncotherad immunotherapy associated to erythropoietin. This is an ASCO Meeting Abstract from the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results